bluebird bio, Inc. (BLUE) Financials
Stock symbol BLUE is outdated, potentially delisted? Maybe it is available on other exchange?
BLUE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 460.2 million | 491.8 million |
| Sept. 30, 2024 | 465.1 million | 470.8 million |
| June 30, 2024 | 545.2 million | 492.2 million |
| March 31, 2024 | 631.5 million | 500.4 million |
BLUE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | -50.6 million | 4.1 million |
| Sept. 30, 2024 | -69.2 million | 2.7 million |
| June 30, 2024 | -66.3 million | 3.2 million |
| March 31, 2024 | -76.5 million | 3.8 million |
BLUE Net Income
No data available :(
BLUE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 62.3 million | 169.4 million | 286.7 million |
| Sept. 30, 2024 | 70.7 million | 173.7 million | 294.4 million |
| June 30, 2024 | 144.1 million | 194.2 million | 320.6 million |
| March 31, 2024 | 212.0 million | 206.8 million | 345.3 million |
BLUE Shares Outstanding
BLUE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | 485000 | 20.8 million | 31.4 million | - |
| Sept. 30, 2024 | 280000 | 23.2 million | 39.8 million | - |
| June 30, 2024 | 59000 | 25.2 million | 50.4 million | - |
| March 31, 2024 | 1.8 million | 25.1 million | 46.3 million | - |
BLUE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | 38.5 million | 22.8 million |
| Sept. 30, 2024 | 10.6 million | 11.8 million |
| June 30, 2024 | 16.1 million | 28.9 million |
| March 31, 2024 | 18.6 million | 25.9 million |
BLUE Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BLUE
Price: $4.97
52 week price:
Earnings Per Share: -20.59 USD
P/E Ratio: -0.24
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.0 million
Ebitda: -74.0 millionMarket Capitalization: 48.7 million